Psoriatic News and Research

RSS
Epidural lidocaine injections show promise for treating psoriasis

Epidural lidocaine injections show promise for treating psoriasis

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

Scientists discover a key starting point for inhibiting inflammation in psoriasis and psoriatic arthritis

Scientists discover a key starting point for inhibiting inflammation in psoriasis and psoriatic arthritis

CHMP recommends approval of upadacitinib (RINVOQ®) for the treatment of adults with active non-radiographic axial spondyloarthritis

CHMP recommends approval of upadacitinib (RINVOQ®) for the treatment of adults with active non-radiographic axial spondyloarthritis

CHMP recommends approval of upadacitinib (RINVOQ®) for the treatment of adults with active non-radiographic axial spondyloarthritis

CHMP recommends approval of upadacitinib (RINVOQ®) for the treatment of adults with active non-radiographic axial spondyloarthritis

Risk of severe COVID-19 in adults with immune-mediated inflammatory diseases and those on immune-modifying therapies

Risk of severe COVID-19 in adults with immune-mediated inflammatory diseases and those on immune-modifying therapies

New AI tool can speed up the diagnosis of psoriatic arthritis by up to 4 years

New AI tool can speed up the diagnosis of psoriatic arthritis by up to 4 years

NYU Langone joins NIH-sponsored program as leading center to discover new targets for autoimmune, inflammatory diseases

NYU Langone joins NIH-sponsored program as leading center to discover new targets for autoimmune, inflammatory diseases

Updated guideline released for managing antirheumatic drugs in patients undergoing hip or knee replacement

Updated guideline released for managing antirheumatic drugs in patients undergoing hip or knee replacement

Use of immunosuppressants for inflammatory rheumatic diseases and the associated risk of severe COVID-19

Use of immunosuppressants for inflammatory rheumatic diseases and the associated risk of severe COVID-19

The impact of COVID-19 on people with systemic autoimmune rheumatic diseases

The impact of COVID-19 on people with systemic autoimmune rheumatic diseases

Study identifies several proteins that protect against disease development

Study identifies several proteins that protect against disease development

HSS study provides insight into real-world medication use for treatment of psoriatic arthritis

HSS study provides insight into real-world medication use for treatment of psoriatic arthritis

Study shows significant decreases in infections among people with psoriatic arthritis

Study shows significant decreases in infections among people with psoriatic arthritis

Researchers identify mechanism behind insufficient treatment efficacy of psoriasis drugs

Researchers identify mechanism behind insufficient treatment efficacy of psoriasis drugs

Real-world data sheds new light on biologic treatment and vaccine hesitancy in psoriasis patients

Real-world data sheds new light on biologic treatment and vaccine hesitancy in psoriasis patients

Scientists discover new cell type in human skin that contributes to inflammatory skin diseases

Scientists discover new cell type in human skin that contributes to inflammatory skin diseases

Immune-mediated inflammatory disease may increase risk of severe COVID-19 outcomes

Immune-mediated inflammatory disease may increase risk of severe COVID-19 outcomes

New clinical trial to test third dose of COVID-19 vaccine for immunocompromised people

New clinical trial to test third dose of COVID-19 vaccine for immunocompromised people

Targeting a skin protein may reduce the severity of psoriasis, study reveals

Targeting a skin protein may reduce the severity of psoriasis, study reveals